Colgate-Palmolive price target raised to $111 from $103 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Colgate-Palmolive to $111 from $103 and keeps an Overweight rating on the shares. The company “posted strong Q2 upside” and “importantly” the high quality and balanced nature of the beat give visibility on sustained organic sales growth outperformance compared to peers, the analyst tells investors in a post-earnings note.